50 signatures reached
To: Tasmanian Health Minister and the State Government
Co-Fund the Royal Hobart Hospital (RHH) Clinical Trials Unit
We, the undersigned members and supporters of the Australian Nursing and Midwifery Federation (ANMF), call on the Tasmanian Health Minister and the State Government to urgently commit to co-funding the Clinical Trials Unit at the Royal Hobart Hospital (RHH).
We urge the Tasmanian Government to:
• Commit to co-funding the Clinical Trials Unit, including staffing, infrastructure, and operational needs.
• Ensure ongoing investment to support sustainable growth and innovation.
• Recognise the Unit as a core component of Tasmania’s public health system, not an optional extra.
We urge the Tasmanian Government to:
• Commit to co-funding the Clinical Trials Unit, including staffing, infrastructure, and operational needs.
• Ensure ongoing investment to support sustainable growth and innovation.
• Recognise the Unit as a core component of Tasmania’s public health system, not an optional extra.
Why is this important?
The Clinical Trials Unit plays a critical role in advancing medical research, improving patient outcomes, and providing Tasmanians with access to cutting-edge treatments that may otherwise be unavailable. It supports innovation, attracts skilled professionals, and contributes to the broader health system through evidence-based care.
Despite its importance, the Unit is currently under pressure due to workload challenges, staffing shortages, and uncertainty around future funding. Without adequate support, the Unit risks being unable to meet demand, compromising both patient care and research capacity.
The Time to Act is Now
The Time to Act is Now
Investing in clinical trials is an investment in the future of healthcare. It ensures Tasmanians benefit from the latest medical advancements and that our health system remains at the forefront of research and treatment.
We stand in solidarity with the staff and patients who rely on this vital service.